Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huaier Granule for Nephrotoxicity in Advanced Hepatobiliary Malignancies
NCT05673824Phase 2Completed
- Sponsor
- Fudan University
- Start
- Jan 2023
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of huaier granule in nephrotoxicity and proteinuria, sponsored by Fudan University. Primary endpoint: Effective rate on proteinuria treatment at 8 weeks. Started Jan 2023; status: completed.
02
Drugs
huaier granule
03
Conditions
nephrotoxicityproteinuria
Beyond the preview
Go deeper on NCT05673824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05673824.